Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Results 1
Date
.webp)
Health Care Rounds Podcast
March 11, 2021
Learn More
Episode 17: Social Determinants of Health with Dr. Lenchus
July 9, 2018
Learn More
Episode 16: Our Take July - Part 1
July 12, 2018
Learn More
Episode 15: Happy Fourth of July!
July 4, 2018
Learn More
Episode 14: Our Take June - Part 2
July 28, 2018
Learn More
Episode 69: Our Take, September 9, 2019
September 9, 2019
Learn More
Episode 68: Our Take, August 26, 2019
August 26, 2019
Learn More
Episode 67: Our Aging Crisis with Bob Roth
August 22, 2019
Learn More
Episode 66: Our Take, August 19, 2019
August 19, 2019
Learn More
Episode 65: Our Take, August 12, 2019
August 12, 2019
Learn More
Darwin's Our Take 6.22.26: Study finds general-purpose LLMs perform better than specialized clinical AI tools
June 22, 2026
Learn More
Darwin's Our Take 6.15.26: GSK grows lung cancer portfolio with $10.6 billion Nuvalent acquisition
June 15, 2026
Learn More
Darwin's Our Take 6.8.26: Feature: Health systems gain AI governance controls as collaborations proliferate
June 8, 2026
Learn More
Darwin's Our Take 6.1.26: Sutter and Allina Health advance plans to combine
June 1, 2026
Learn More
Darwin's Our Take 5.18.26: UnitedHealth’s Optum Rx PBM to shift to transparent, fee-based model
May 18, 2026
Learn More
Darwin's Our Take 5.11.26: UPMC to acquire Trinity Health from CommonSpirit, WakeMed to merge with Advocate’s Atrium Health
May 11, 2026
Learn More
Darwin's Our Take: Regeneron’s ‘groundbreaking’ Otarmeni gains FDA approval
May 4, 2026
Learn More
Darwin's Our Take: OpenAI unveils GPT-Rosalind to support life sciences research
April 27, 2026
Learn More
Darwin's Our Take: Do AI chatbots pose risks for consumers and providers?
April 20, 2026
Learn More
Darwin's Our Take: Gilead announces third acquisition of 2026
April 13, 2026
Learn More
Darwin's Our Take: The uptick in Big Pharma M&A activity continues
April 6, 2026
Learn More
Darwin's Our Take: Nearly one-third of U.S. adults use AI to get health information, surveys show
March 30, 2026
Learn More
Darwin's Our Take: Sutter, Allina Health announce intent to merge
March 23, 2026
Learn More
Darwin's Our Take: Servier, Agilent, Medtronic, and UHS announce significant acquisitions
March 16, 2026
Learn More
Darwin's Our Take: Amazon unveils Connect Health platform
March 9, 2026
Learn More
Darwin's Our Take: Big Pharma, home health and digital health companies notch big-ticket deals
March 2, 2026
Learn More
Darwin's Our Take: Humana’s CenterWell acquires Florida-based primary care provider MaxHealth
February 23, 2026
Learn More
Darwin's Our Take: Feature: A rare FDA refusal, CDC grant cuts, and proposed ACA exchange changes
February 16, 2026
Learn More
Darwin's Our Take: Lilly’s, Novo Nordisk’s share prices roller-coaster following earnings reports
February 9, 2026
Learn More
Darwin's Our Take: Botox, Trulicity, Xolair among drugs selected for next round of Medicare price negotiations
February 2, 2026
Learn More
Darwin's Our Take: Health insurance CEOs catch flak at House hearings on affordability, blame others for high costs
January 25, 2026
Learn More
Darwin's Our Take: Anthropic, OpenAI unveil new AI tools for health care enterprises
January 18, 2026
Learn More
Darwin's Our Take: OpenAI introduces ChatGPT Health to further integrate users' health information
January 11, 2026
Learn More
Darwin's Our Take: FDA approves Novo Nordisk’s Wegovy pill
January 5, 2026
Learn More
Darwin's Our Take: Another 9 drugmakers agree to most-favored-nation pricing on certain products
December 22, 2025
Learn More
Darwin's Our Take: Lilly’s ‘triple G’ candidate exceeds analysts’ expectations
January 14, 2026
Learn More
Our Take: Eli Lilly achieves market value of $1 trillion
December 8, 2025
Learn More
Our Take: Abbott to boost its diagnostics portfolio with $21 billion acquisition of Exact Sciences
November 24, 2025
Learn More
Our Take: CMS launches payment model to lower Medicaid drug spending
November 17, 2025
Learn More
Our Take: Pfizer wins bidding war to acquire Metsera
November 10, 2025
Learn More
Our Take: PBM Express Scripts to ditch rebates, Centene and CVS Health take huge write-downs
November 3, 2025
Learn More
Our Take: An uptick in health system collaborations and affiliations
October 27, 2025
Learn More
Our Take: Amazon to offer pharmacy kiosks at One Medical clinics
October 13, 2025
Learn More
Our Take: New California laws take aim at PBMs and more
October 20, 2025
Learn More
Our Take: Feature: Notable recent transactions among Big Pharma and life sciences companies
September 22, 2025
Learn More
Darwin's Our Take: Genmab agrees to acquire Dutch biotech Merus for $8 billion
October 6, 2025
Learn More
%20Large.jpeg)
Our Take: Feature - GAO report on physician consolidation
September 29, 2025
Learn More
Our Take: Feature: CBO report analyzes 565% increase in 340B drug spending over 11 years
September 15, 2025
Learn More
Our Take: Evernorth invests $3.5 billion in Shields Health, HonorHealth acquires Evernorth Care clinics
September 8, 2025
Learn More
Our Take: Epic shines a spotlight on generative AI projects at annual Users Group Meeting
August 25, 2025
Learn More
Our Take: HHS, FDA finalize rule allowing states to import prescription drugs from Canada
December 5, 2020
Learn More
.jpg)
Our Take: Walmart introduces its health insurance agency, launches co-branded MA plans with Clover Health
October 12, 2020
Learn More
Our Take: Increasingly concentrated health insurance markets may be harming consumers, providers, AMA study suggests
October 19, 2021
Learn More
Our Take: Health System Executive Survey — observations from the editor
October 26, 2020
Learn More
Our Take: Intermountain Healthcare, Sanford Health to merge
November 2, 2020
Learn More
Our Take: CMS approves controversial waiver, finalizes rules, penalizes hospitals for readmissions
November 9, 2020
Learn More
Our Take: Pfizer’s COVID-19 vaccine demonstrates more than 90% efficacy, early data show; Lilly’s antibody drug is first to receive EUA
November 16, 2020
Learn More
Our Take: Amazon rattles the pharmacy industry with its long-awaited launch
November 23, 2020
Learn More
.jpg)
Our Take: CMS reverses course, issues final rule to update Stark Law
December 7, 2020
Learn More
.jpg)
Our Take: Pfizer, BioNTech nab first FDA authorization of a COVID-19 vaccine
December 14, 2020
Learn More
Our Take: 2020’s (other) top stories
December 21, 2020
Learn More
Our Take: Pharma companies sign spate of deals before year-end
January 4, 2021
Learn More
Our Take: The demise of a proclaimed disrupter: Haven comes to a halt
January 11, 2021
Learn More
.jpg)
Our Take: CMS announces NextGen ACO results — and they are impressive
January 18, 2021
Learn More
.jpg)
Our Take: UnitedHealthcare launches new virtual primary care service; parent company records $15 billion profit for 2020
January 25, 2021
Learn More
Our Take: Leading drugmakers persist in the battle against COVID-19
February 1, 2021
Learn More
Our Take: HCA, insurers report billions in profits for 2020, though some saw decline in Q4
February 8, 2021
Learn More
Our Take: DOJ asks Supreme Court to uphold the ACA, coalition seeks to expand the health care law
February 15, 2021
Learn More
Our Take: 14 health systems come together to create health data startup Truveta
February 22, 2021
Learn More
Our Take: J&J’s COVID-19 vaccine gains authorization, other vaccine makers provide updates
March 1, 2021
Learn More
Our Take: Merck to help manufacture J&J’s COVID-19 vaccine, acquire Pandion, withdraw Keytruda indication
March 8, 2021
Learn More
Our Take: Merck, Ridgeback report early data indicating molnupiravir’s promise as potential COVID-19 treatment
March 15, 2021
Learn More
Our Take: Amazon Care takes a potentially giant step forward
March 22, 2021
Learn More
Our Take: Increasing challenges plague hospitals one year into COVID-19, OIG report indicates
March 29, 2021
Learn More
Our Take: Roundup of the latest COVID-19 vaccine news
April 5, 2021
Learn More
Our Take: Charity care spending at nonprofit hospitals falls short in new study
April 12, 2021
Learn More
Our Take: States pause use of J&J vaccine while FDA, CDC assess potential risk of rare blood clots
April 19, 2021
Learn More
Our Take: Insurers continue to reap profits, announce acquisitions in Q1
April 26, 2021
Learn More
Our Take: Humana to buy remaining stake in Kindred at home for $5.7 billion
May 3, 2021
Learn More
Our Take: Walmart to acquire on-demand telehealth provider MeMD
May 10, 2021
Learn More
.jpg)
Our Take: BD to spin off diabetes business into new publicly traded company
May 17, 2021
Learn More
Our Take: JPMorgan Chase picks up where Haven left off
May 24, 2021
Learn More
Our Take: HCA Healthcare to partner with Google Cloud on custom analytics tools
June 7, 2021
Learn More
Our Take: FDA grants accelerated approval to Biogen’s Alzheimer’s drug, creating more controversy
June 14, 2021
Learn More
.jpg)
Our Take: Beaumont Health and Spectrum Health in talks to form a new 22-hospital health system
June 21, 2021
Learn More
Our Take: Blues plans fund new startup to address high drug prices
June 28, 2021
Learn More
Our Take: As delta becomes dominant strain, U.S. COVID-19 cases increase nearly 11% in one week
July 12, 2021
Learn More
Our Take: Oral arguments in Pfizer lawsuit renew focus on case that could have industry-wide implications
July 19, 2021
Learn More
Our Take: Health systems, insurers take a ‘wait and see; stance on Aduhelm
July 26, 2021
Learn More
.jpg)
Our Take: As FDA approves first interchangeable insulin biosimilar, insurers take steps to restrict use of biosimilars
August 2, 2021
Learn More
Our Take: COVID-19 appears to be an independent risk factor for heart attack, stroke, large study shows
August 9, 2021
Learn More
.jpg)
Our Take: Honor Technologies acquires Home Instead with goal of scaling up high-quality senior home care
August 16, 2021
Learn More
Our Take: J&J, Cerner announce shake-ups in top leadership, Google Health splitting up
August 23, 2021
Learn More
Our Take: Vaccine update: Pfizer, BioNTech get full FDA nod, Moderna completes its BLA submission
September 1, 2021
Learn More
Our Take: Biden administration takes a more aggressive stance in the battle against COVID-19
September 13, 2021
Learn More
Our Take: Walgreens to invest nearly $1 billion in Shields Health Solutions
September 27, 2021
Learn More
.jpg)
Our Take: Northwell Health, Walgreens form new affiliation to improve care for tre-state area
September 20, 2021
Learn More
Our Take: Merck, Ridgeback could be first to receive EUA for COVID-19 pill
October 4, 2021
Learn More
Our Take: Intermountain, Presbyterian, SSM Health launch member-led company to ‘transform’ digital health care
October 11, 2021
Learn More
Our Take: Boehringer Ingelheim joins list of drugmakers facing possible penalties for violating 340B statute
October 18, 2021
Learn More
Our Take: Value-based payment for prescription drugs: Will industry or the feds lead the way?
October 25, 2021
Learn More
Our Take: Two new PBMs target high drug prices, lack of transparency
November 1, 2021
Learn More
Our Take: New COVID-19 mandates could require millions more to be vaccinated by Jan. 4 unless lawsuits prevail
November 8, 2021
Learn More
Our Take: Public health officials face steep challenge in fight against COVID-19 misinformation, KFF survey indicates
November 15, 2021
Learn More
Our Take: HHS will require health insurers to report data on prescription drug costs and coverage
November 22, 2021
Learn More
Our Take: FDA panel votes to authorize Merck, Ridgeback’s molnupiravir, despite lower efficacy in final trial results
December 6, 2021
Learn More
Our Take: Update on the omicron variant, vaccines, and other COVID-19 treatments
December 13, 2021
Learn More
Our Take: 2021 in the rearview
December 19, 2021
Learn More
Our Take: Flurry of M&A activity marks end of 2021, spills over into 2022
January 10, 2022
Learn More
Our Take: Hospitals feel the strain of staff shortages with the omicron-fueled COVID-19 surge
January 17, 2022
Learn More